Patents Assigned to BIOUSIAN BIOSYSTEM, INC.
  • Glucagon-like peptide-1 glycopeptides
    Patent number: 9234023
    Abstract: Methods and materials are provided for the production of glycosylated GLP-1 peptides that exhibit improved properties. The methods and materials of the present invention may be used for treatment of metabolic conditions, such as Syndrome X and diabetes.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: January 12, 2016
    Assignee: Biousian Biosystems, Inc.
    Inventors: Edward J. Bilsky, Robin Polt, Hanoch Senderowitz
  • Delta-opioid receptor selective analgesics
    Patent number: 8575309
    Abstract: Methods and materials are provided for the production of glycosylated peptides that exhibit high affinity and specificity for delta opioid receptors. The methods and materials of the present invention may be used for treatment of conditions involving pain, such as acute pain and nociceptic pain, neuralgia and myalgia.
    Type: Grant
    Filed: December 8, 2009
    Date of Patent: November 5, 2013
    Assignee: Biousian Biosystems, Inc.
    Inventors: Robin Polt, Edward J. Bilsky
  • DELTA-OPIOID RECEPTOR SELECTIVE ANALGESICS
    Publication number: 20120101043
    Abstract: Methods and materials are provided for the production of glycosylated peptides that exhibit high affinity and specificity for delta opioid receptors. The methods and materials of the present invention may be used for treatment of conditions involving pain, such as acute pain and nociceptic pain, neuralgia and myalgia.
    Type: Application
    Filed: December 8, 2009
    Publication date: April 26, 2012
    Applicant: BIOUSIAN BIOSYSTEM, INC.
    Inventors: Robin Polt, Edward J. Bilsky